博迅生物
(920504)
| 流通市值：4.60亿 | | | 总市值：11.66亿 |
| 流通股本：1709.19万 | | | 总股本：4333.31万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 42,126,073.58 | 29,676,167.4 | 37,429,456.89 | 76,433,131.18 |
| 交易性金融资产 | 30,097,399.7 | 65,062,356.64 | 50,664,628.78 | 28,833,181.53 |
| 应收票据及应收账款 | 29,396,726.02 | 26,752,996.05 | 24,569,301.81 | 12,865,554.93 |
| 其中：应收票据 | 5,347,799.71 | 3,317,095.03 | 5,769,346.8 | 9,335,397.23 |
| 应收账款 | 24,048,926.31 | 23,435,901.02 | 18,799,955.01 | 3,530,157.7 |
| 应收款项融资 | 1,500,037.58 | 958,673.17 | 18,737 | 2,965,634.83 |
| 预付款项 | 1,232,504.82 | 1,184,353.03 | 2,817,637.89 | 1,677,942.8 |
| 其他应收款合计 | 196,001.69 | 173,411.74 | 181,047.96 | 40,532.02 |
| 其中:应收利息 | 76,487.69 | 51,534.26 | 26,852.06 | 2,441.1 |
| 存货 | 25,092,883.74 | 25,846,548.71 | 26,683,117.93 | 26,089,113.71 |
| 一年内到期的非流动资产 | 1,260,352.12 | 1,260,352.12 | 22,341,513.23 | 22,181,988.11 |
| 其他流动资产 | 20,604,244.86 | 2,565,205.34 | 2,469,872.82 | 3,616,081.12 |
| 流动资产合计 | 151,506,224.11 | 153,480,064.2 | 167,175,314.31 | 174,703,160.23 |
| 非流动资产: | | | | |
| 长期应收款 | 15,829,541.21 | 15,699,602.5 | 15,570,651.74 | 15,507,416.09 |
| 固定资产 | 22,042,337.14 | 22,601,341.63 | 23,193,411.16 | 22,138,713.66 |
| 在建工程 | 22,707,719.61 | 20,733,645.68 | 18,983,794.28 | 17,936,265.66 |
| 使用权资产 | 4,246,181.08 | 4,478,053.9 | 4,709,926.72 | 4,941,799.54 |
| 无形资产 | 9,675,644.84 | 9,730,974.9 | 9,719,863.74 | 9,636,382.76 |
| 长期待摊费用 | 3,547,998.27 | 2,715,665.12 | 2,778,695.43 | 2,963,145.99 |
| 递延所得税资产 | 4,101,923.33 | 3,968,031.42 | 3,806,286.69 | 4,016,672.06 |
| 其他非流动资产 | 21,378,585.65 | 11,874,057.93 | - | - |
| 非流动资产合计 | 103,529,931.13 | 91,801,373.08 | 78,762,629.76 | 77,140,395.76 |
| 资产总计 | 255,036,155.24 | 245,281,437.28 | 245,937,944.07 | 251,843,555.99 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 15,767,697.17 | 16,777,511.41 | 14,692,940.64 | 18,265,023.44 |
| 应付账款 | 15,767,697.17 | 16,777,511.41 | 14,692,940.64 | 18,265,023.44 |
| 合同负债 | 2,356,769.39 | 1,494,872.25 | 1,322,846.27 | 2,131,821.91 |
| 应付职工薪酬 | 2,888,527.3 | 2,449,613.02 | 2,108,178.84 | 2,865,878.31 |
| 应交税费 | 2,504,507.67 | 1,747,633.75 | 2,156,754.33 | 1,817,655.93 |
| 其他应付款合计 | 3,604,555.63 | 2,403,833.35 | 2,933,251.81 | 5,657,473.91 |
| 一年内到期的非流动负债 | 2,359,242.69 | 2,354,629.07 | 2,063,245.44 | 1,959,179.67 |
| 其他流动负债 | 5,513,596.62 | 2,881,709.8 | 6,322,153.32 | 6,012,906.94 |
| 流动负债合计 | 34,994,896.47 | 30,109,802.65 | 31,599,370.65 | 38,709,940.11 |
| 非流动负债: | | | | |
| 租赁负债 | 17,950,114.29 | 17,801,462.96 | 18,041,704.03 | 17,990,402.69 |
| 递延收益 | 1,888,085 | 2,042,834 | 1,164,250 | 1,219,000 |
| 递延所得税负债 | 167,701.62 | 199,357.94 | 234,722.15 | 265,964.28 |
| 非流动负债合计 | 20,005,900.91 | 20,043,654.9 | 19,440,676.18 | 19,475,366.97 |
| 负债合计 | 55,000,797.38 | 50,153,457.55 | 51,040,046.83 | 58,185,307.08 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 43,333,100 | 43,333,100 | 43,333,100 | 43,333,100 |
| 资本公积 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 |
| 盈余公积 | 18,611,085.85 | 18,611,085.85 | 18,611,085.85 | 18,611,085.85 |
| 未分配利润 | 23,501,040.35 | 18,593,662.22 | 18,363,579.73 | 17,123,931.4 |
| 归属于母公司股东权益合计 | 200,035,357.86 | 195,127,979.73 | 194,897,897.24 | 193,658,248.91 |
| 股东权益合计 | 200,035,357.86 | 195,127,979.73 | 194,897,897.24 | 193,658,248.91 |
| 负债和股东权益合计 | 255,036,155.24 | 245,281,437.28 | 245,937,944.07 | 251,843,555.99 |
| 公告日期 | 2025-10-30 | 2025-08-27 | 2025-04-28 | 2025-04-07 |
| 审计意见(境内) | | | | 标准无保留意见 |